reglab/housing_qa huggingface dataset:
MA Gen L ch 94c § 19a (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 19a - Emergency Contraception

Section 19A. (a) As used in this section ''emergency contraception'' shall, unless the context clearly requires otherwise, mean any drug approved by the federal Food and Drug Administration as a contraceptive method for use after sexual intercourse.  (b) Notwithstanding any other law, a licensed pharmacist may dispense emergency contraception in accordance with written, standardized procedures or protocols developed by an actively practicing physician registered with the commissioner to distribute or dispense a controlled substance in the course of professional practice pursuant to section 7 if such procedures or protocols are filed at the pharmacist's place of practice and with the board of registration in pharmacy before implementation.  (c) Before dispensing emergency contraception authorized under this section, a pharmacist shall complete a training program approved by the commissioner on emergency contraception, which training shall include but not be limited to proper documentation, quality assurance, and referral to additional services, including appropriate recommendation that the patient follow-up with a medical practitioner.  (d) A pharmacist dispensing emergency contraception under this section shall annually provide to the department of public health the number of times such emergency contraception is dispensed. Reports made pursuant to this section shall not identify any individual patient, shall be confidential and shall not be public records as defined by clause twenty-sixth of section 7 of chapter 4.  (e) The department of public health, board of registration in medicine, and board of registration in pharmacy shall adopt regulations to implement this section.
MA Gen L ch 94c § 19b1/2 (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 19b1/2 - Exchange of Naloxone or Other Opioid Antagonist Between Registered Entities

Section 19B1/2. Notwithstanding any special or general law to the contrary, a municipality or non-municipal public agency that is duly registered pursuant to subsection (g) of section 7 may convey or exchange naloxone or another opioid antagonist approved by the department to or with another duly registered entity to ensure the availability and use of unexpired naloxone or other approved opioid antagonist; provided, however, that such an exchange shall be recorded in a memorandum between the registered entities in a manner prescribed by the department.
MA Gen L ch 94c § 19c (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 19c - High Opiate Overdose Area Pharmacies Required to Maintain Continuous Supply of Naloxone Rescue Kits or Opioid Antagonist Medications

Section 19C. The board of registration in pharmacy shall promulgate regulations requiring pharmacies located in areas with high incidents of opiate overdose, as determined by the board in consultation with the department of public health, to maintain a continuous supply of naloxone rescue kits or opioid antagonist medications, as defined in section 19B. Pharmacists employed in locations covered by the regulations shall be subject to the requirements of section 19B.
MA Gen L ch 94c § 19d (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 19d - Supply Limitations for Opiate Prescriptions; Exception for Palliative Care

Section 19D. (a) When issuing a prescription for an opiate to an adult patient for outpatient use for the first time, a practitioner shall not issue a prescription for more than a 7–day supply. A practitioner shall not issue an opiate prescription to a minor for more than a 7–day supply at any time and shall discuss with the parent or guardian of the minor the risks associated with opiate use and the reasons why the prescription is necessary.  (b) Notwithstanding subsection (a), if, in the professional medical judgment of a practitioner, more than a 7–day supply of an opiate is required to treat the adult or minor patient's acute medical condition or is necessary for the treatment of chronic pain management, pain associated with a cancer diagnoses or for palliative care, then the practitioner may issue a prescription for the quantity needed to treat such acute medical condition, chronic pain, pain associated with a cancer diagnosis or pain experienced while the patient is in palliative care. The condition triggering the prescription of an opiate for more than a 7–day supply shall be documented in the patient's medical record and the practitioner shall indicate that a non-opiate alternative was not appropriate to address the medical condition.  (c) Notwithstanding subsections (a) and subsection (b), this section shall not apply to medications designed for the treatment of substance abuse or opioid dependence.
MA Gen L ch 94c § 20 (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 20 - Oral Prescriptions

[See Order of the Commissioner of Public Health, dated April 6, 2020, (2019 MA EO H20-24) related to the COVID-19 State of Emergency, for potential impact on the terms of this section.]  Section 20. (a) Upon receiving an oral prescription for a controlled substance or instrument described in section twenty-seven from an authorized practitioner, the pharmacist shall immediately reduce the prescription to writing on a prescription form and shall record the name, address and registration number of the practitioner and the name of any expressly authorized representative, the date of the prescription, the name, dosage and strength per dosage unit of the controlled substance, the serial number assigned to the prescription by the dispensing pharmacy, the name of said pharmacy, the name and address of the patient unless it is a veterinary prescription, the directions for use and any cautionary statements required, and a statement indicating the number of times to be refilled.  (b) If the prescribing practitioner is not known to the pharmacist, he shall make a reasonable effort to determine that the oral authorization came from a registered practitioner.  (c) Whenever a practitioner prescribes a controlled substance by oral prescription, the practitioner shall cause an electronic prescription for the prescribed controlled substance to be delivered to the dispensing pharmacy within 2 days; provided, however, that if the practitioner has received an exception from using an electronic prescription from the commissioner pursuant to subsection (h) of section 23, the practitioner shall, within a period of not more than 7 days or such shorter period that is required by federal law, cause a written prescription for the prescribed controlled substance to be delivered to the dispensing pharmacy. The written prescription may be delivered to the pharmacy in person or by mail, but shall be postmarked within 7 days or such shorter period that is required by federal law. When an electronic or written prescription is issued pursuant to this subsection, the practitioner shall indicate on the electronic or written prescription that such prescription is being issued to document an oral prescription. Upon receipt, the dispensing pharmacy shall attach said prescription to the oral prescription which the pharmacy has reduced to writing. Persons charged with the enforcement of this chapter shall report violations of this subsection to the board of registration in medicine, the board of registration in dentistry, the board of registration in podiatry or the board of registration in veterinary medicine, whichever is applicable, and to the commissioner or board of registration in pharmacy, whichever is applicable. The requirements of this subsection shall not apply to controlled substances in Schedule VI of section 3.
MA Gen L ch 94c § 20a (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 20a - Radiopharmaceutical Drugs

Section 20A. Notwithstanding any other provisions of this chapter, a prescription for a radiopharmaceutical drug shall be dispensed only to an individual authorized by the nuclear regulatory commission to possess and administer such drug.  Upon receiving an oral prescription for a radiopharmaceutical drug from an authorized practitioner, the nuclear pharmacist shall immediately reduce the prescription to writing and shall record the name, address and registration number of the practitioner and the name of any expressly authorized representative, the date of the prescription, the name and the dose of the radiopharmaceutical drug, the serial number assigned to the prescription by the dispensing nuclear pharmacy, the name of said nuclear pharmacy, the name and address of the patient and any specific instructions required. If the radiopharmaceutical drug is not administered, it shall be returned to the nuclear pharmacy to be disposed of in accordance with requirements established by the nuclear regulatory commission and any applicable law and the nuclear pharmacist shall note on the prescription form the amount of the radiopharmaceutical drug that has been returned and disposed of as required.
MA Gen L ch 94c § 21b (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 21b - Advertisement and Sale of Prescription Lock Boxes by Pharmacies

Section 21B. (a) For the purposes of this section, the following words shall have the following meanings unless the context clearly requires otherwise:  ''Lock box'', a box with a locking mechanism that cannot be tampered with or opened without extreme force.  ''Pharmacy'', a facility under the direction or supervision of a registered pharmacist which is authorized to dispense controlled substances; provided, however, that ''pharmacy'' shall not include an institutional pharmacy or a pharmacy department except as otherwise provided in 247 CMR.  ''Prescription drug'', a drug which, under federal law, is required, prior to being dispensed or delivered, to be labeled with the statement ''Caution, federal law prohibits dispensing without prescription'' or a drug which is required by applicable federal or state law or regulation to be dispensed pursuant only to a prescription drug order.  (b) A pharmacy registered in the commonwealth to dispense schedule II, III, IV or V prescription drugs shall make available prescription lock boxes for sale at each store location. Pharmacies shall make customers aware of the availability of the lock boxes by displaying a sign on or near the pharmacy counter that: (i) is at least 4 inches by 5 inches; and (ii) includes the following statement in legibly printed font: ''Lock boxes for securing your prescription medications are available at this pharmacy''.
MA Gen L ch 94c § 22 (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 22 - Contents of Prescription Written by Practitioner

Section 22. (a) A practitioner who dispenses a controlled substance by issuing a written or electronic prescription shall state on the prescription the name, address and registration number of the practitioner, the date of delivery of the prescription, the name, dosage and strength per dosage unit of the controlled substance, the name and address of the patient unless it is a veterinary prescription, the directions for use and any cautionary statements required, and a statement indicating the number of times to be refilled.  (b) A practitioner who dispenses by delivering to an ultimate user a controlled substance which is not for immediate administration shall package the controlled substance in a container, affixing to the container a label bearing the practitioner's name and address, the date of dispensing, the name of the patient unless it is a veterinary prescription, the name, dosage and strength per dosage unit, of the controlled substance, directions for use and any necessary cautionary statements.  (c) Any prescription issued by a practitioner for an opioid substance contained in Schedule II of section 3 shall include a notation on the prescription that the patient may fill, upon request, the prescription in compliance with subsection (d.75) of section 18 in an amount not to exceed the full prescribed quantity.
MA Gen L ch 94c § 24 (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 24 - Dispensing by Practitioner for Narcotic Drug Research or Treatment of Drug Dependent Persons

Section 24. (a) If the commissioner determines that a research subject or patient is receiving a controlled substance from more than one source and in quantities which he determines to be harmful to the health of such research subject or patient, said commissioner shall so notify the practitioners who have dispensed the controlled substance.  (b) In order to prevent the dispensing of controlled substances to the same individual from multiple sources or the unlawful diversion of controlled substances, the commissioner shall, pursuant to the provisions of chapter 30A, adopt rules and regulations for carrying out the provisions of this section.
MA Gen L ch 94c § 24b (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 24b - Mean and Median Quantity and Volume of Prescriptions for Opiates; Notification of Practitioner's Own Percentile Ranking

Section 24B. The department shall annually determine, through the prescription drug monitoring system established in section 24A, the mean and median quantity and volume of prescriptions for opiates contained in Schedules II and III of section 3 issued by practitioners registered under section 7; provided, however, that mean and median prescription quantities and volumes shall be determined within categories of practitioners of a similar specialty or practice type as determined by the department.  The department shall work in conjunction with the respective boards of licensure to annually determine each practitioner's Schedule II and Schedule III opiate prescribing quantity and volume and the practitioner's standing with regard to the mean and median quantity and volume for the practitioner's category of specialty or practice type; provided, however, that the practitioner's standing shall be expressed as a percentile ranking for the practitioner within the practitioner's category. Each practitioner whose prescribing exceeds the mean or median within the practitioner's category shall be sent notice of the practitioner's percentile ranking in a manner determined by the department. Any practitioner may request the practitioner's own percentile ranking within the practitioner's own category of practice. The ranking determined for each practitioner shall be confidential, and shall be distributed by the department or by the relevant board of licensure only to the practitioner to which the information pertains. Such information shall not; (a) constitute a public record as defined in clause twenty-sixth of section 7 of chapter 4; (b) be admissible as evidence in a civil or criminal proceeding; or (c) be the sole basis for investigation by a licensure board.  The department shall also coordinate with the respective boards of licensure to make resources available to prescribers regarding ways to change prescribing practices and incorporate alternative pain management options into a prescriber's practice.
MA Gen L ch 94c § 25 (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 25 - Restrictions

Section 25. No person—  (1) who is subject to the requirements of sections six and seven and twelve to seventeen, inclusive, shall dispense a controlled substance in violation of said section seventeen;  (2) shall distribute or dispense a controlled substance not authorized by his registration to another registrant or other authorized person or manufacturer a controlled substance not authorized by his registration;  (3) who is a registrant shall distribute a controlled substance in violation of section sixteen;  (4) shall remove, alter, or obliterate a symbol or label required by federal law and the laws of the commonwealth;  (5) shall refuse or fail to make, keep, or furnish any record, report, notification, declaration, order or order form, statement, invoice, or information required under this chapter;  (6) shall refuse any entry into any premises or inspection authorized by this chapter;  (7) shall remove, break, injure, or deface a seal placed upon controlled substances pursuant to this chapter, or remove or dispose of substances so placed under seal;  (8) shall use, to his own advantage, or reveal, other than to duly authorized officers or employees of the United States or of the commonwealth or to the courts when relevant in any judicial proceeding under this chapter, any information acquired in the course of an inspection authorized by this chapter concerning any method or process which is a trade secret.  No person who is a registrant shall manufacture a controlled substance in Schedule I or II which is not expressly authorized by his registration.
MA Gen L ch 94c § 26 (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 26 - Distribution in Course of Business in Violation of Sec. 16 or Furnishing False Information in Application, etc., Prohibited

Section 26. No person who is a registrant shall knowingly or intentionally;  (1) distribute a controlled substance classified in Schedule I or II in the course of his legitimate business, except pursuant to an order or an order form as required by section sixteen; or  (2) furnish false or fraudulent material information in, or omit any material information from, any application, report, record, or other document required to be made, kept, or filed pursuant to the provisions of this chapter.
MA Gen L ch 94c § 27 (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 27 - Sale of Hypodermic Syringes or Hypodermic Needles

Section 27. Hypodermic syringes or hypodermic needles for the administration of controlled substances by injection may be sold in the commonwealth only by a pharmacist or wholesale druggist licensed under the provisions of chapter 112, a manufacturer of or dealer in surgical supplies or a manufacturer of or dealer in embalming supplies.
MA Gen L ch 94c § 28 (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 28 - Jurisdiction of Superior Court

Section 28. Upon petition of the board of registration in pharmacy or the commissioner in the case of a pharmacy, or upon petition of the commissioner in any case, the superior court shall have jurisdiction to restrain or enjoin a violation of this chapter.
MA Gen L ch 94c § 29 (2021)
2021 Massachusetts General Laws|Part I - Administration of the Government|Title XV - Regulation of Trade|Chapter 94c - Controlled Substances Act|Section 29 - Educational Programs for Prevention of Abuse of Controlled Substances

Section 29. (a) The commissioner in cooperation with the commissioner of mental health and the commissioner of education shall carry out educational programs designed to prevent and deter misuse and abuse of controlled substances. In connection with these programs he shall:  (1) promote better recognition of the problem of misuse and abuse of controlled substances within the regulated industry and among interested groups and organizations;  (2) assist the regulated industry and interested groups and organizations in contributing to the reduction of misuse and abuse of controlled substances;  (3) consult with interested groups and organizations to aid them in solving administrative and organizational problems;  (4) evaluate procedures, projects, techniques and controls conducted or proposed as part of educational programs on misuse and abuse of controlled substances;  (5) disseminate the results of research on misuse and abuse of controlled substances to promote a better public understanding of what problems exist and what can be done to combat them; and  (6) assist the attorney general in the education and training of state and local law enforcement officials in their efforts to control misuse and abuse of controlled substances.  (b) The commissioner shall encourage research on misuse and abuse of controlled substances. In connection with the research, and in furtherance of the enforcement of this chapter, he shall:  (1) establish methods to assess accurately the effects of controlled substances and identify and characterize those with potential for abuse;  (2) make studies and undertake programs of research to:  (i) develop new or improved approaches, techniques, systems, equipment and devices to strengthen the enforcement of this chapter;  (ii) determine patterns of misuse and abuse of controlled substances and the social effects thereof; and  (iii) improve methods for preventing, predicting, understanding and dealing with the misuse and abuse of controlled substances; and  (3) enter into contracts with public agencies, institutions of higher education and private organizations or individuals for the purpose of conducting research, demonstrations or special projects which bear directly on misuse and abuse of controlled substances.  (c) The commissioner and the commissioner of mental health may enter into contracts for educational and research activities.